2026
conference-abstract
OpenAlex
M Marques Cami, Laia Vergés, A Elosua Gonzalez, J M Huguet et autres
Abstract Background The terminal ileum (TI) stands out as the most frequently affected segment of the gastrointestinal tract in Crohn’s disease (CD). Assessing mucosal inflammation only in the TI by ileocolonoscopy (IC) may lead to underestimating the overall ileal involvement. Small bowel …
es
(code pays fourni par la source)
2026
conference-abstract
OpenAlex
Arnau Artero, P Borras Garriga, L Balcells, D Ruiz et autres
Abstract Background Inflammatory bowel disease (IBD) and its treatments may increase opportunistic infections, but the link with human papillomavirus (HPV) remains unclear1. Immunosuppression and smoking can hinder viral clearance, favouring persistence and premalignant lesions. Despite guideline recommendations2,3, Spanish data on precancerous lesions, …
es
(code pays fourni par la source)
2026
conference-abstract
OpenAlex
A Gutiérrez Casbas, M Barreiro-de Acosta, M L De Castro Parga, Lucía Madero Velázquez et autres
Abstract Background Mirikizumab (MIRI) has shown efficacy over placebo in ulcerative colitis (UC) based on the data from the pivotal clinical trials. However, these results still need to be confirmed in clinical practice. This study aims to assess the short-term real-world effectiveness …
es
(code pays fourni par la source)